The OncAlert oral cancer product line from Vigilant Biosciences Inc, Fort Lauderdale, Fla, is now available in select markets. The company’s OncAlert oral cancer product line includes the OncAlert oral cancer rapid test and the OncAlert oral cancer lab test, available in countries accepting the CE mark. The tests are based on technology that accurately measures […]
For Matthew Kim, the idea for his company came when he was taking his mother to doctor visits for her cancer treatments. She was on her third battle with oral cancer, while Kim had a consulting firm and the fortunate flexibility to take her to her chemotherapy, radiation and rehabilitation.
When Matthew Kim, founder and CEO of Vigilant Biosciences in Fort Lauderdale started his company in 2011, he quickly found funding to be a serious challenge. Ultimately, he persuaded an out-of-state investor to help, but in his most recent financing round, he received support from venVelo, an early-stage angel fund in Orlando, the Florida Institute […]
The Mistake: I fell in love with a technology before understanding the impact or value the technology can have in the real world. In my prior medical startup, I created a drug delivery platform which had a very novel way of delivering medication to the lungs systemically. I licensed and started the company and raised […]
According to the World Health Organization, there are more than 529,000 new cases of oral (lip, oral cavity, and pharynx) cancer each year worldwide, with mortality rates reaching up to 292,000 deaths each year.1 In the United States, more than 48,000 individuals will be diagnosed with oral cancer this year with more than 9,500 deaths resulting […]
Florida’s startup and expanding companies so far this year have raised $1 billion in venture capital and angel investments, more than double 2015’s total of $459.89 million, according to a MoneyTree Report released Friday. While on track for the best year since 2000, Florida companies’ venture capital during the third quarter is less than 1 […]
Vigilant Biosciences, a developer of solutions that aid in the early detection and intervention of cancer, has received a Phase I Small Business Innovation Research grant of $219,454 from the National Institute of Dental and Craniofacial Research. The 15-month grant will fund research by Vigilant Biosciences to develop a diagnostic test that utilizes optical imaging […]
Head and neck cancer is a growing challenge with more than 650,000 new cases and more than 360,000 deaths worldwide each year. Historically, the death rate associated with this cancer is particularly high due to late-stage diagnosis and intervention. More than 40 percent of those diagnosed with oral cancer die within five years.
Vigilant Biosciences, an oral cancer testing company, announced that it has raised a total of $10.5 million in Series B financing. The second phase of the Series B round brought in $5 million and investors in this phase included White Owl Capital Partners, venVelo and others. Investment in this round also came from a group of private […]